Biotek-snakken — November 2022
-
Jeg har også været med i mange år på både godt og ondt. Jeg tror virkelig, at vi vil se en raket først i det nye år. Nu kommer der først 3. kvartals regnskab onsdag d. 9. november og så venter vi på data fra NGAL testen, som kommer i 4. kvartal 2022. De har fået nogle rigtige kompetente kræfter med i selskabet, så jeg tror på rigtige gode data og indsendelse af De Novo ansøgning i slut 4. kvartal 2022. NGAL-testen er blevet tildelt Breakthrough Device-betegnelse af FDA.
-
God nyhed fra Saniona, som måske står foran en genejsning til gamle niveauer. Dagens nyhed er et skridt på vejen, men man venter også, at Saniona snart melder ud omkring en ny partner til Tesomet, som klar kan blive deres helt store cashcow: https://finance.yahoo.com/news/saniona-anti-inflammatory-anti-fibrotic-070000986.html
-
Redeye endorses Saniona’s pre-clinical progress with drug candidate SAN903, that has compelling anti-inflammatory and anti-fibrotic properties. Potential indications include inflammatory bowel disease and fibrotic disorders such as chronic kidney disease and idiopathic pulmonary fibrosis (“IPF”). The company now guides that it is ready to start the regulatory process for a first clinical study. We will review our valuation in relation to Saniona’s Q3 report and likely raise our base case.
-
BioNTech Q3 Profit Down; Lifts FY22
COVID-19 Vaccine Revenue View https://www.proinvestor.com/investornyt/901056/biontech-q3-profit-down-lifts-fy22-covid-19-vaccine-revenue-view -
Tak Fandel...Jeg ser på den igen.
-
Cantargia presents new data at SITC 2022 supporting nadunolimab's promising antitumor clinical efficacy
Data shows nadunolimab dual mechanism potently reduces levels of tumor-promoting molecules https://www.proinvestor.com/boards/107598
-
Bioporto anmoder FDA om marketingsgodkendelse af NGAL-test - GENT https://www.proinvestor.com/investornyt/903572/bioporto-anmoder-fda-om-marketingsgodkendelse-af-ngal-test-gent
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind